Hims & Hers Health EBIT 2020-2024 | HIMS

Hims & Hers Health annual and quarterly EBIT history from 2020 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Hims & Hers Health EBIT for the quarter ending September 30, 2024 was $0.022B, a 361.56% decline year-over-year.
  • Hims & Hers Health EBIT for the twelve months ending September 30, 2024 was $0.043B, a 205.53% decline year-over-year.
  • Hims & Hers Health 2023 annual EBIT was $-0.029B, a 57.13% decline from 2022.
  • Hims & Hers Health 2022 annual EBIT was $-0.069B, a 40.29% decline from 2021.
  • Hims & Hers Health 2021 annual EBIT was $-0.115B, a 659.65% increase from 2020.
Hims & Hers Health Annual EBIT
(Millions of US $)
2023 $-29
2022 $-69
2021 $-115
2020 $-15
2019 $-74
2018 $
Hims & Hers Health Quarterly EBIT
(Millions of US $)
2024-09-30 $22
2024-06-30 $11
2024-03-31 $10
2023-12-31 $-0
2023-09-30 $-9
2023-06-30 $-9
2023-03-31 $-11
2022-12-31 $-12
2022-09-30 $-20
2022-06-30 $-20
2022-03-31 $-17
2021-12-31 $-22
2021-09-30 $-28
2021-06-30 $-17
2021-03-31 $-48
2020-12-31 $-5
2020-09-30 $-3
2020-06-30 $-1
2020-03-31 $-6
2019-12-31
2019-09-30 $-0
2019-06-30 $-0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $6.961B $0.872B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.714B 55.57
Tempus AI (TEM) United States $7.994B 0.00
Inspire Medical Systems (INSP) United States $5.693B 177.56
IRhythm Technologies (IRTC) United States $3.453B 0.00
Privia Health (PRVA) United States $2.701B 225.10
Enovis (ENOV) United States $2.693B 17.94
Azenta (AZTA) United States $2.440B 130.24
Clover Health Investments (CLOV) United States $2.230B 0.00
Omnicell (OMCL) United States $2.070B 67.71
Schrodinger (SDGR) United States $1.819B 0.00
10x Genomics (TXG) United States $1.796B 0.00
Phreesia (PHR) United States $1.669B 0.00
Butterfly Network (BFLY) United States $0.748B 0.00
Standard BioTools (LAB) United States $0.588B 0.00
Talkspace (TALK) United States $0.537B 0.00
Fulgent Genetics (FLGT) United States $0.515B 0.00
TruBridge (TBRG) United States $0.362B 105.43
Nyxoah SA (NYXH) Belgium $0.354B 0.00
Health Catalyst (HCAT) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.235B 0.00
Pulmonx (LUNG) United States $0.230B 0.00
American Well (AMWL) United States $0.169B 0.00
EUDA Health Holdings (EUDA) Singapore $0.096B 0.00
P3 Health Partners (PIII) United States $0.069B 0.00
CareCloud (CCLD) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
111 (YI) China $0.047B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.020B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00